Sanofi (NASDAQ:GCVRZ)

CAPS Rating: No stars

Results 1 - 2 of 2

Recs

0
Member Avatar BioInvestor2013 (< 20) Submitted: 11/15/2014 8:56:44 PM : Outperform Start Price: $1.03 GCVRZ Score: -26.54

investors know gcvrz is long time in my portfolio Approval 100%

Recs

0
Member Avatar MajorBob04 (99.59) Submitted: 11/14/2014 11:59:33 PM : Outperform Start Price: $1.03 GCVRZ Score: -26.54

The FDA just approved Lemtrada so the achievement of sales objectives is possible, maybe even probable. Look for the stock to outperform the market, starting with a pop on Monday, 11/17/2014.

Results 1 - 2 of 2

Featured Broker Partners


Advertisement